biobusiness
Q&A: From FDA to Industry
Q&A: From FDA to Industry
Kerry Grens | Sep 27, 2016
Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.
The Growth of Iowa Biotech
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016
The state’s industry draws inspiration from medicine as well as agriculture.
Abbott Acquires Diagnostics Firm
Abbott Acquires Diagnostics Firm
Kerry Grens | Feb 2, 2016
In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.
TS Picks: CRISPR Patent Edition
TS Picks: CRISPR Patent Edition
Kerry Grens | Jan 5, 2016
A challenge to the first CRISPR patent just got teeth.
Another Obesity Drug Trial Death
Another Obesity Drug Trial Death
Kerry Grens | Dec 2, 2015
A second patient taking an experimental medication to treat Prader-Willi Syndrome has died of blood clots.
Treating Toxoplasmosis
Treating Toxoplasmosis
Jef Akst | Sep 25, 2015
While one company hikes the price of an old drug to treat the parasitic infection, academic researchers report that an approved blood pressure medication could be just what the doctor ordered.
Direct-to-Consumer Liquid Biopsy
Direct-to-Consumer Liquid Biopsy
Kerry Grens | Sep 13, 2015
Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.
Biotech Buys Autoimmune Firm for $7B
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
Another CAR-T IPO
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.
23andMe Enters Drug Development
23andMe Enters Drug Development
Kerry Grens | Mar 12, 2015
The personal genomics firm announces plans to make medicines.